PAHC
Phibro Animal Health Corporation
NASDAQ: PAHC · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$32.96
-6.89% today
Updated 2026-11-06
Market cap
$1.58B
P/E ratio
15.99
P/S ratio
1.04x
EPS (TTM)
$2.43
Dividend yield
1.27%
52W range
$28 – $60
Volume
0.2M
Phibro Animal Health Corporation (PAHC) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$32.96
12-Month target
$71.25
2030 Target
—
Intrinsic (DCF)
$47.21
Financial forecast
| Metric | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| Revenue | $0.9B | $1.0B | $1.0B | $1.3B | $1.5B |
| EPS | — | — | — | — | — |
CAGR applied: — (capped 20%) · P/E: 15.99x (capped 25x) · Margin: 6.57%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.